
mdCurrent Conference Report: 72nd Annual Scientific Sessions of the American Diabetes Association Adding basal insulin (insulin glargine) as a second-line treatment after metformin is superior to adding sitagliptin in achieving glycemic control in patients with type 2 diabetes, according to study data presented at the 72nd Annual (2012) Scientific Sessions…
Read more »
Early basal insulin in patients with type 2 diabetes achieves glycemic control better than sitagliptin, but with greater risk of hypoglycemia
mdCurrent Conference Report: 72nd Annual Scientific Sessions of the American Diabetes Association Adding basal insulin (insulin glargine) as a second-line treatment after metformin is superior to adding sitagliptin in achieving glycemic control in patients with type 2 diabetes, according to study data presented at the 72nd Annual (2012) Scientific Sessions…
Read more »